Cargando…
Hepatotoxicity in immune checkpoint inhibitors: A pharmacovigilance study from 2014–2021
Adverse events(AEs) related to hepatotoxicity have been reported in patients treated with immune checkpoint inhibitors (ICIs). As the number of adverse events increases, it is necessary to assess the differences in each immune checkpoint inhibitor regimen. The purpose of this study was to examine th...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990950/ https://www.ncbi.nlm.nih.gov/pubmed/36881599 http://dx.doi.org/10.1371/journal.pone.0281983 |